ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Aayush Wellness Limited has submitted its Annual Report for the financial year 2025-26. The report includes financial statements, statutory reports, and corporate information.
Aayush Wellness Limited has issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Aayush Wellness Limited announced the re-appointment of Gavadu Patil as Non-Executive Non-Independent Director and the appointment of A. Raghavendra Rao & Associates as Statutory Auditor.
Aayush Wellness approved the reappointment of a director and the appointment of new statutory auditors. The board also scheduled the 42nd Annual General Meeting.
Aayush Wellness confirmed to BSE that they have no undisclosed information that would impact the company's recent share price movement or performance.
Aayush Wellness Limited has launched its new Lung Care Tablets, expanding its preventive healthcare portfolio. This product targets consumers concerned about respiratory health.
Aayush Wellness Limited announced postal ballot results with shareholders approving the appointment of statutory auditors and two non-executive directors. All three ordinary resolutions passed with significant majority.
Aayush Wellness reported Q1 FY27 consolidated revenue of ₹33.11 Crore, reflecting 46% YoY growth. Consolidated PAT stood at ₹1.42 Crore for the quarter.
Aayush Wellness Ltd reported revenue from operations of ₹33.1 Cr (+46.5% YoY) and net profit of ₹1.4 Cr (+16.7% YoY) for Q1 FY27.